Search results
Results from the WOW.Com Content Network
Ionis Pharmaceuticals Stock Price And Volume Action Ionis Pharmaceuticals (NASDAQ:IONS) is currently down 17.47% to a price of $46.29. Tuesday the stock has been traded at a volume of 2.55 million ...
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
For premium support please call: 800-290-4726 more ways to reach us
Ionis (IONS) Q1 adjusted loss per share was wider than the year-ago figure. The company maintains its guidance for 2021. Ionis (IONS) Q1 Loss Widens Year Over Year, Sales Miss
(For example, 500 shares at $32 may become 1000 shares at $16.) Many major firms like to keep their price in the $25 to $75 price range. A US share must be priced at $1 or more to be covered by NASDAQ. If the share price falls below that level, the stock is "delisted" and becomes an OTC (over the counter stock). A stock must have a price of $1 ...
Year World market cap Number of listed companies Millions of US$ % of GDP; 1975 1,149,245 27.2 14,577 1980 2,525,736 29.6 17,273 1985 4,684,978 47.0 20,555
For premium support please call: 800-290-4726 more ways to reach us
Stocks (also capital stock, or sometimes interchangeably, shares) consist of all the shares [a] by which ownership of a corporation or company is divided. [1] A single share of the stock means fractional ownership of the corporation in proportion to the total number of shares.